Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

Walters MJ, Wang Y, Lai N, Baumgart T, Zhao BN, Dairaghi DJ, Bekker P, Ertl LS, Penfold ME, Jaen JC, Keshav S, Wendt E, Pennell A, Ungashe S, Wei Z, Wright JJ, Schall TJ.

J Pharmacol Exp Ther. 2010 Oct;335(1):61-9. doi: 10.1124/jpet.110.169714. Epub 2010 Jul 21.

2.

Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice.

Kostadinova FI, Baba T, Ishida Y, Kondo T, Popivanova BK, Mukaida N.

J Leukoc Biol. 2010 Jul;88(1):133-43. doi: 10.1189/jlb.1109768. Epub 2010 Mar 24.

3.

Development of monocytes, macrophages, and dendritic cells.

Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K.

Science. 2010 Feb 5;327(5966):656-61. doi: 10.1126/science.1178331. Review. Erratum in: Science. 2010 Dec 3;330(6009):1319.

4.

Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Weber B, Saurer L, Mueller C.

Semin Immunopathol. 2009 Jul;31(2):171-84. doi: 10.1007/s00281-009-0156-5. Epub 2009 Jun 17. Review.

PMID:
19533135
5.

Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages.

Kelsall B.

Mucosal Immunol. 2008 Nov;1(6):460-9. doi: 10.1038/mi.2008.61. Epub 2008 Sep 17. Review.

6.

Exploring the full spectrum of macrophage activation.

Mosser DM, Edwards JP.

Nat Rev Immunol. 2008 Dec;8(12):958-69. doi: 10.1038/nri2448. Review. Erratum in: Nat Rev Immunol.2010 Jun;10(6):460.

7.

Suppression of experimental colitis in mice by CD11c+ dendritic cells.

Qualls JE, Tuna H, Kaplan AM, Cohen DA.

Inflamm Bowel Dis. 2009 Feb;15(2):236-47. doi: 10.1002/ibd.20733.

PMID:
18839426
8.

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, Butcher EC.

Nat Immunol. 2008 Nov;9(11):1253-60. doi: 10.1038/ni.1658. Epub 2008 Oct 5.

9.

Antigen-presentation properties of plasmacytoid dendritic cells.

Villadangos JA, Young L.

Immunity. 2008 Sep 19;29(3):352-61. doi: 10.1016/j.immuni.2008.09.002. Review.

10.

Plasmacytoid dendritic cells mediate oral tolerance.

Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, Asselin-Paturel C, Trinchieri G, Kaiserlian D.

Immunity. 2008 Sep 19;29(3):464-75. doi: 10.1016/j.immuni.2008.06.017.

11.

Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.

Mikami S, Nakase H, Yamamoto S, Takeda Y, Yoshino T, Kasahara K, Ueno S, Uza N, Oishi S, Fujii N, Nagasawa T, Chiba T.

J Pharmacol Exp Ther. 2008 Nov;327(2):383-92. doi: 10.1124/jpet.108.141085. Epub 2008 Aug 20.

12.

Adaptive immunity in inflammatory bowel disease: state of the art.

Kaser A, Blumberg RS.

Curr Opin Gastroenterol. 2008 Jul;24(4):455-61. doi: 10.1097/MOG.0b013e328304d60d. Review.

PMID:
18622159
13.

Dendritic cells in intestinal immune regulation.

Coombes JL, Powrie F.

Nat Rev Immunol. 2008 Jun;8(6):435-46. doi: 10.1038/nri2335. Review.

14.

Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.

Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G.

Gastroenterology. 2008 Jun;134(7):2025-35. doi: 10.1053/j.gastro.2008.02.085. Epub 2008 Mar 5.

PMID:
18439426
15.

Direct multiplexed measurement of gene expression with color-coded probe pairs.

Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K.

Nat Biotechnol. 2008 Mar;26(3):317-25. doi: 10.1038/nbt1385. Epub 2008 Feb 17.

PMID:
18278033
16.

The role of dendritic cells in the development of acute dextran sulfate sodium colitis.

Berndt BE, Zhang M, Chen GH, Huffnagle GB, Kao JY.

J Immunol. 2007 Nov 1;179(9):6255-62.

17.

Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells.

Abe K, Nguyen KP, Fine SD, Mo JH, Shen C, Shenouda S, Corr M, Jung S, Lee J, Eckmann L, Raz E.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17022-7. Epub 2007 Oct 17.

18.

Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.

Sainathan SK, Hanna EM, Gong Q, Bishnupuri KS, Luo Q, Colonna M, White FV, Croze E, Houchen C, Anant S, Dieckgraefe BK.

Inflamm Bowel Dis. 2008 Jan;14(1):88-99.

19.

Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.

Nguyen DD, Maillard MH, Cotta-de-Almeida V, Mizoguchi E, Klein C, Fuss I, Nagler C, Mizoguchi A, Bhan AK, Snapper SB.

Gastroenterology. 2007 Oct;133(4):1188-97. Epub 2007 Jul 12.

20.

Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine.

Stenstad H, Svensson M, Cucak H, Kotarsky K, Agace WW.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10122-7. Epub 2007 Jun 5.

Items per page

Supplemental Content

Write to the Help Desk